Literature DB >> 28089527

MRI in radiotherapy for lung cancer: A free-breathing protocol at 3T.

Shivani Kumar1, Robba Rai2, Daniel Moses3, Callie Choong2, Lois Holloway4, Shalini Kavita Vinod5, Gary Liney6.   

Abstract

Imaging plays a significant role in radiation therapy. Improvements in treatment delivery require sophisticated imaging technologies to define tumor volume accurately. Magnetic resonance imaging scans can provide morphological and functional information and are increasingly being used in imaging for radiation therapy; however, for lung cancer, most protocols are based on breath-hold imaging and noncompliance to breath-hold maneuver can lead to significant artifacts. For patients presenting for lung cancer radiation therapy, maintaining a breath hold can be impossible. This paper describes a completely free-breathing lung magnetic resonance imaging protocol for use in radiation therapy for lung cancer. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28089527     DOI: 10.1016/j.prro.2016.10.008

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  3 in total

1.  Feasibility of free breathing Lung MRI for Radiotherapy using non-Cartesian k-space acquisition schemes.

Authors:  Shivani Kumar; Robba Rai; Alto Stemmer; Sonal Josan; Lois Holloway; Shalini Vinod; Daniel Moses; Gary Liney
Journal:  Br J Radiol       Date:  2017-09-13       Impact factor: 3.039

2.  Feasibility of pulmonary MRI for nodule detection in comparison to computed tomography.

Authors:  Nan Yu; Chuangbo Yang; Guangming Ma; Shan Dang; Zhanli Ren; Shaoyu Wang; Yong Yu
Journal:  BMC Med Imaging       Date:  2020-05-20       Impact factor: 1.930

3.  Free-breathing radial 3D fat-suppressed T1-weighted gradient echo (r-VIBE) sequence for assessment of pulmonary lesions: a prospective comparison of CT and MRI.

Authors:  Nan Yu; Haifeng Duan; Chuangbo Yang; Yong Yu; Shan Dang
Journal:  Cancer Imaging       Date:  2021-12-20       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.